{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:05:53Z","timestamp":1789074353614,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V115C-136"],"award-info":[{"award-number":["V115C-136"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["VTA114-V1-3-1"],"award-info":[{"award-number":["VTA114-V1-3-1"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["VGHUST114-G4-3-2"],"award-info":[{"award-number":["VGHUST114-G4-3-2"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112B-017"],"award-info":[{"award-number":["V112B-017"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V115C-133"],"award-info":[{"award-number":["V115C-133"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V113C-181"],"award-info":[{"award-number":["V113C-181"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007354","name":"Yen Tjing Ling Medical Foundation","doi-asserted-by":"publisher","award":["CI-114-21"],"award-info":[{"award-number":["CI-114-21"]}],"id":[{"id":"10.13039\/501100007354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007354","name":"Yen Tjing Ling Medical Foundation","doi-asserted-by":"publisher","award":["CI-113-18"],"award-info":[{"award-number":["CI-113-18"]}],"id":[{"id":"10.13039\/501100007354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007354","name":"Yen Tjing Ling Medical Foundation","doi-asserted-by":"publisher","award":["CI-115-28"],"award-info":[{"award-number":["CI-115-28"]}],"id":[{"id":"10.13039\/501100007354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2321-B-A49-013"],"award-info":[{"award-number":["114-2321-B-A49-013"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2311-B-075-001"],"award-info":[{"award-number":["112-2311-B-075-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2320-B-075-002"],"award-info":[{"award-number":["112-2320-B-075-002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["115-2314-B-075-056-MY3"],"award-info":[{"award-number":["115-2314-B-075-056-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2320-B-075-007"],"award-info":[{"award-number":["113-2320-B-075-007"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2321-B-A49-009"],"award-info":[{"award-number":["111-2321-B-A49-009"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2320-B-A49-022-MY3"],"award-info":[{"award-number":["114-2320-B-A49-022-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-075-032"],"award-info":[{"award-number":["114-2314-B-075-032"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2320-B-075-004"],"award-info":[{"award-number":["114-2320-B-075-004"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2320-B-075-010"],"award-info":[{"award-number":["114-2320-B-075-010"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2321-B-A49-007"],"award-info":[{"award-number":["112-2321-B-A49-007"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejphar.2026.179236","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:59:20Z","timestamp":1786978760000},"page":"179236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of CXCR4-induced angiogenesis to block choroidal neovascularization and restore retinal function in age-related macular degeneration by in silico-selected small molecules"],"prefix":"10.1016","volume":"1033","author":[{"given":"Shih-Jie","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5749-7175","authenticated-orcid":false,"given":"Chia-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Hsing","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0783-605X","authenticated-orcid":false,"given":"Yu-Jer","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Ou-Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chieh","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kak-Shan","family":"Shia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Shin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Huang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Long","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-8485","authenticated-orcid":false,"given":"De-Kuang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chien","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-5755","authenticated-orcid":false,"given":"Shih-Hwa","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179236_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000514539","article-title":"Reactivation of CNV after discontinuation of bevacizumab treatment of age-related macular degeneration","volume":"244","author":"Amarakoon","year":"2021","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ejphar.2026.179236_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","article-title":"Mechanisms of age-related macular degeneration","volume":"75","author":"Ambati","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179236_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood.2023022658","article-title":"A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome","volume":"144","author":"Badolato","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2026.179236_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bcp.2009.06.010","article-title":"Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4","volume":"78","author":"Bodart","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179236_bib5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/jm901530b","article-title":"Synthesis and structure\u2212Activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-Cell tropic (X4) HIV-1 replication","volume":"53","author":"Bridger","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179236_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106328","article-title":"Zedoarondiol inhibits atherosclerosis by regulating monocyte migration and adhesion via CXCL12\/CXCR4 pathway","volume":"182","author":"Chai","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10456-025-09977-5","article-title":"G protein-coupled receptor GPR182 negatively regulates sprouting angiogenesis via modulating CXCL12-CXCR4 axis signaling","volume":"28","author":"Chen","year":"2025","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ejphar.2026.179236_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12951-024-02482-9","article-title":"Migrasomes from adipose derived stem cells enrich CXCL12 to recruit stem cells via CXCR4\/RhoA for a positive feedback loop mediating soft tissue regeneration","volume":"22","author":"Chen","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2026.179236_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jconrel.2025.01.066","article-title":"CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma","volume":"379","author":"Cheng","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2026.179236_bib10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s12272-011-0906-5","article-title":"A python-based docking program utilizing a receptor bound ligand shape: pythdock","volume":"34","author":"Chung","year":"2011","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.oret.2018.01.006","article-title":"Real-world outcomes of anti\u2013vascular endothelial growth factor therapy in neovascular age-related macular degeneration in the United States","volume":"2","author":"Ciulla","year":"2018","journal-title":"Ophthalmology Retina"},{"key":"10.1016\/j.ejphar.2026.179236_bib12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ophtha.2020.11.024","article-title":"Genetic risk, lifestyle, and age-related macular degeneration in Europe: the EYE-RISK consortium","volume":"128","author":"Colijn","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2026.179236_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2015.10.008","article-title":"Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa","volume":"161","author":"Coscas","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2026.179236_bib14","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1182\/bloodadvances.2023010407","article-title":"Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor","volume":"7","author":"Crees","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ejphar.2026.179236_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173936","article-title":"CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2\/4 inhibitors in glioblastoma multiforme","volume":"897","author":"Daniele","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179236_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/2040206619829382","article-title":"Mozobil\u00ae (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration","volume":"27","author":"De Clercq","year":"2019","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.ejphar.2026.179236_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/AAC.38.4.668","article-title":"Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100","volume":"38","author":"De Clercq","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2026.179236_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1200\/JCO.2004.07.131","article-title":"Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-hodgkin's lymphoma","volume":"22","author":"Devine","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179236_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s11011-022-01155-6","article-title":"CXCR4 as possible druggable target linking inflammatory bowel disease and Parkinson's disease","volume":"38","author":"Dogra","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2026.179236_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm0198-072","article-title":"AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor","volume":"4","author":"Donzella","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.179236_bib21","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3892\/mmr.2016.5179","article-title":"CXCL12\/CXCR4 axis regulates neovascularization and lymphangiogenesis in sutured corneas in mice","volume":"13","author":"Du","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2026.179236_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12272-025-01533-5","article-title":"Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening","volume":"48","author":"Elkamhawy","year":"2025","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13287-020-02073-z","article-title":"A novel small molecule CXCR4 antagonist potently mobilizes hematopoietic stem cells in mice and monkeys","volume":"12","author":"Fang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejphar.2026.179236_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114150","article-title":"A fragment integrational approach to GPCR inhibition: identification of a high affinity small molecule CXCR4 antagonist","volume":"231","author":"Fang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179236_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112410","article-title":"Design, synthesis, and biological characterization of a new class of symmetrical polyamine-based small molecule CXCR4 antagonists","volume":"200","author":"Fang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179236_bib26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12272-024-01503-3","article-title":"Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration","volume":"47","author":"Fei","year":"2024","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/cells9010032","article-title":"Dual CXCR4 and E-Selectin inhibitor, GMI-1359, shows anti-bone metastatic effects and synergizes with docetaxel in prostate cancer cell intraosseous growth","volume":"9","author":"Festuccia","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179236_bib28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","article-title":"Antibiotics for emerging pathogens","volume":"325","author":"Fischbach","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179236_bib29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Ghasemi Falavarjani","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.ejphar.2026.179236_bib30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.preteyeres.2008.05.002","article-title":"The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration","volume":"27","author":"Grisanti","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bcp.2005.05.035","article-title":"AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor","volume":"70","author":"Hatse","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179236_bib32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ceo.14262","article-title":"Environmental influences on ophthalmic conditions: a scoping review","volume":"51","author":"Heilenbach","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejphar.2026.179236_bib33","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.qai.0000137371.80695.ef","article-title":"Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection","volume":"37","author":"Hendrix","year":"2004","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ejphar.2026.179236_bib34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2026.179236_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","article-title":"Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration","volume":"99","author":"Holz","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2026.179236_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000348532","article-title":"CXCR7\/CXCR4\/CXCL12 axis regulates the proliferation, migration, survival and tube formation of choroid-retinal endothelial cells","volume":"50","author":"Jin","year":"2013","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175456","article-title":"Potential of Orlistat to induce apoptotic and antiangiogenic effects as well as inhibition of fatty acid synthesis in breast cancer cells","volume":"939","author":"Jovanki\u0107","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179236_bib38","first-page":"1","article-title":"Noninvasive electroretinographic procedures for the Study of the mouse retina","volume":"8","author":"Kinoshita","year":"2018","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.ejphar.2026.179236_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","article-title":"Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment","volume":"120","author":"Krzystolik","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejphar.2026.179236_bib40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12272-019-01123-2","article-title":"Role of stem cell mobilization in the treatment of ischemic diseases","volume":"42","author":"Kwon","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib41","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2026.179236_bib42","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1167\/iovs.09-3802","article-title":"Evaluation of CXCR4 inhibition in the prevention and intervention model of laser-induced choroidal neovascularization","volume":"51","author":"Lee","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2026.179236_bib43","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1096\/fj.06-7359com","article-title":"The SDF-1\/CXCR4 ligand\/receptor pair is an important contributor to several types of ocular neovascularization","volume":"21","author":"Lima e Silva","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2026.179236_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114578","article-title":"Cryo-EM structure of monomeric CXCL12-bound CXCR4 in the active state","volume":"43","author":"Liu","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.179236_bib45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1359-6446(02)02483-2","article-title":"Structure-based virtual screening: an overview","volume":"7","author":"Lyne","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2026.179236_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/irv.12047","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance","volume":"7","author":"McKimm-Breschkin","year":"2013","journal-title":"Influenza Other Respi. Viruses"},{"key":"10.1016\/j.ejphar.2026.179236_bib47","article-title":"CXCR4 chemokine antagonist scores a first FDA approval for WHIM syndrome","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.179236_bib48","first-page":"245","article-title":"Inflammatory choroidal neovascularization. Middle East African","volume":"16","author":"Neri","year":"2009","journal-title":"journal of ophthalmology"},{"key":"10.1016\/j.ejphar.2026.179236_bib49","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2026.179236_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","article-title":"The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis","volume":"28","author":"Petit","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejphar.2026.179236_bib51","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64427-6","article-title":"Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model","volume":"161","author":"Rakoczy","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2026.179236_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40364-025-00778-y","article-title":"Targeting the chemokine receptor CXCR4 for cancer therapies","volume":"13","author":"Rueda","year":"2025","journal-title":"Biomarker Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2425795122","article-title":"Structural mechanisms underlying the modulation of CXCR4 by diverse small-molecule antagonists","volume":"122","author":"Sang","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2026.179236_bib54","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41598-018-19594-6","article-title":"Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor","volume":"8","author":"Sato","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179236_bib55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.186.8.1383","article-title":"Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4","volume":"186","author":"Schols","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2026.179236_bib56","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","article-title":"Global burden of dry age-related macular degeneration: a targeted literature review","volume":"43","author":"Schultz","year":"2021","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2026.179236_bib57","doi-asserted-by":"crossref","DOI":"10.3791\/53502","article-title":"A mouse model for laser-induced choroidal neovascularization","author":"Shah","year":"2015","journal-title":"Journal of Visualized Experiments"},{"key":"10.1016\/j.ejphar.2026.179236_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/c6b85ec4-996d-4daf-863a-44260a888470","article-title":"Choroid sprouting assay: an ex vivo model of microvascular angiogenesis","volume":"8","author":"Shao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179236_bib59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12974-023-02998-1","article-title":"Succinate-induced macrophage polarization and RBP4 secretion promote vascular sprouting in ocular neovascularization","volume":"20","author":"Shen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2026.179236_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015433118","article-title":"A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment","volume":"118","author":"Song","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2026.179236_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/07357907.2017.1422512","article-title":"Knockdown of CXCR4 inhibits CXCL12-Induced angiogenesis in HUVECs through downregulation of the MAPK\/ERK and PI3K\/AKT and the Wnt\/\u03b2-Catenin pathways","volume":"36","author":"Song","year":"2018","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ejphar.2026.179236_bib62","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMp068185","article-title":"The price of sight\u2014ranibizumab, bevacizumab, and the treatment of macular degeneration","volume":"355","author":"Steinbrook","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179236_bib63","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cpdd.1302","article-title":"Pharmacokinetics and pharmacodynamics of Burixafor Hydrobromide (GPC-100), a novel C-X-C chemokine receptor 4 antagonist and mobilizer of Hematopoietic Stem\/Progenitor cells, in mice and healthy subjects","volume":"12","author":"Sukhtankar","year":"2023","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ejphar.2026.179236_bib64","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bab.2199","article-title":"Evaluation of anti-EGFR potential of quinazoline derivatives using molecular docking: an in silico approach","volume":"69","author":"Tanveer","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ejphar.2026.179236_bib65","doi-asserted-by":"crossref","DOI":"10.3791\/61677","article-title":"An Ex vivo choroid sprouting assay of ocular microvascular angiogenesis","author":"Tomita","year":"2020","journal-title":"Journal of visualized experiments"},{"key":"10.1016\/j.ejphar.2026.179236_bib66","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1517\/14712598.8.11.1797","article-title":"Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells","volume":"8","author":"Uy","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ejphar.2026.179236_bib67","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/biom12121813","article-title":"Establishment of a cell line stably expressing the growth hormone secretagogue receptor to identify Crocin as a ghrelin agonist","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.179236_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119108","article-title":"Nuezhenide of the fruits of Nuzhenzi (Ligustrum lucidum Ait.) is a functional analog of ghrelin","volume":"339","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.179236_bib69","article-title":"The CXCR4\/miR-1910-5p\/MMRN2 axis is involved in corneal neovascularization by affecting vascular permeability","volume":"64","author":"Wang","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2026.179236_bib70","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.ejphar.2026.179236_bib71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41435-024-00258-7","article-title":"CXCR4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: a prospective, single-center, observational study","volume":"25","author":"Xue","year":"2024","journal-title":"Gene Immun."},{"key":"10.1016\/j.ejphar.2026.179236_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174322","article-title":"Intervertebral foramen injection of plerixafor attenuates neuropathic pain after chronic compression of the dorsal root ganglion: possible involvement of the down-regulation of Nav1.8 and Nav1.9","volume":"908","author":"Yang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179236_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110550","article-title":"CXCR4+ monocytes promote neovascularization in wet age-related macular degeneration","volume":"259","author":"Yang","year":"2025","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib74","doi-asserted-by":"crossref","first-page":"229","DOI":"10.34133\/bmr.0229","article-title":"Epitranscriptomic modulation of TET2 inhibition suppressed SARS-CoV-2 infection and blocked viral nucleocapsid protein in induced-pluripotent-stem-cell-derived cardiomyocyte screening models","volume":"29","author":"Yang","year":"2025","journal-title":"Biomater. Res."},{"key":"10.1016\/j.ejphar.2026.179236_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911730","article-title":"Protective effect of CXCR4 antagonist DBPR807 against ischemia-reperfusion injury in a rat and porcine model of myocardial infarction: potential adjunctive therapy for percutaneous coronary intervention","volume":"23","author":"Yeh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179236_bib76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.omtm.2019.06.001","article-title":"Expression of a CARD slows the retinal degeneration of a geographic atrophy mouse model","volume":"14","author":"Young","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ejphar.2026.179236_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197085","article-title":"Protective effect of CXCR4 antagonist CX807 in a rat model of hemorrhagic stroke","volume":"21","author":"Yu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179236_bib78","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3892\/mmr.2022.12821","article-title":"SDF-1\u03b1\/CXCR4 signaling promotes capillary tube formation of human retinal vascular endothelial cells by activating ERK1\/2 and PI3K pathways in vitro","volume":"26","author":"Yuan","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2026.179236_bib79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12951-021-01231-6","article-title":"Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2026.179236_bib80","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3109\/02713683.2011.593107","article-title":"Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in choroidal neovascularization in a laser-induced mouse model","volume":"36","author":"Zhang","year":"2011","journal-title":"Curr. Eye Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:06:06Z","timestamp":1789070766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":80,"alternative-id":["S0014299926007181"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179236","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of CXCR4-induced angiogenesis to block choroidal neovascularization and restore retinal function in age-related macular degeneration by in silico-selected small molecules","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179236"}}